| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 2,127.39 | 945.13 | 3,253 | 430.52 |
Depreciation | -1,349.95 | -1,236.43 | -561.56 | -432.23 |
Tax paid | -406.85 | -13.17 | -41.86 | 25.39 |
Working capital | -5,179.41 | -888.49 | 3,200.15 | 1,619.85 |
Other operating items | ||||
Operating | -4,808.82 | -1,192.96 | 5,849.73 | 1,643.53 |
Capital expenditure | 1,382.69 | 7,567.58 | 1,672.05 | 1,584.58 |
Free cash flow | -3,426.13 | 6,374.62 | 7,521.78 | 3,228.11 |
Equity raised | 51,146.55 | 50,012.43 | 43,027.83 | 43,349.81 |
Investing | 11.67 | -1,824.52 | -993.53 | -978.04 |
Financing | 12,421.34 | 13,751.64 | 13,268.25 | 12,869.36 |
Dividends paid | 0 | 0 | 0 | 0 |
Net in cash | 60,153.43 | 68,314.17 | 62,824.32 | 58,469.24 |
The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.
IMVEXXY is a vaginal insert designed to lessen pain during sexual activity after menopause which is manufactured by Mayne Pharma.
The warning letter detailed substantial violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals at the facility.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
